Spectral Diagnostics R&D
This article was originally published in The Gray Sheet
Executive Summary
Firm will use the majority of a recent $3.9 mil. investment by Technology Partnerships Canada to further research a strip-based, 15-minute, point-of-care West Nile Virus diagnostic test in an effort to bring the product to market via 510(k) within the next couple years, the company says. TPC expects its investment to be repaid through rapid infectious disease test royalties over the next 10 years...